Jie Dong

hokkaido university

H指数:39

被引数:4,439

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The long pentraxin 3: the invisible loom weaving the warp and weft of tumor destiny

长五聚素3：编织肿瘤命运经纬的隐形织机

Frontiers in Immunology

IF5.9

2025-12-170

OAAI

Late course adaptive radiotherapy based on tumor volume reduction decreases Gastrointestinal toxicity for abdominal lymph node metastasis of hepatocellular carcinoma

基于肿瘤体积缩小的晚期自适应放射治疗可降低肝细胞癌腹盆腔淋巴结转移的胃肠毒性。

SCIENTIFIC REPORTS

IF3.9

2025-05-200

Efficacy of radiotherapy combined with targeted therapy and immunotherapy for lymph node metastasis of liver cancer

放射治疗联合靶向治疗和免疫治疗对肝癌淋巴结转移的疗效

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

IF2.8

2025-04-010

Tislelizumab plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy for elderly patients with inoperable locally advanced esophageal squamous cell carcinoma: a multicenter, randomized, parallel-controlled, phase II clinical trial

Tislelizumab联合同步放化疗与同步放化疗治疗不能手术的局部晚期食管鳞状细胞癌老年患者的比较: 一项多中心、随机、平行对照、II期临床试验

BMC CANCER

IF3.4

2025-02-250

OAAI

In situ blockade of TNF-TNFR2 axis via oncolytic adenovirus improves antitumor efficacy in solid tumors (vol 33, pg 670, 2025)

通过溶瘤腺病毒在原位阻断TNF-TNFR2轴可增强实体瘤的抗肿瘤疗效（第33卷，第670页，2025年）

MOLECULAR THERAPY

IF12

2025-01-010

PRE

Survival benefit and spatial properties of tertiary lymphoid structures in esophageal squamous cell carcinoma with neoadjuvant therapies

新辅助治疗食管鳞状细胞癌的生存效益和三级淋巴结构的空间特性

CANCER LETTERS

IF10.1

2024-10-010

PRE

Iparomlimab and tuvonralimab (QL1706) with definitive chemoradiotherapy for locally advanced esophageal squamous cell carcinoma: An open-label phase II study

伊帕罗利单抗和图沃纳利单抗（QL1706）联合确定性放化疗治疗局部晚期食管鳞状细胞癌：一项开放标签的II期研究

ANNALS OF ONCOLOGY

IF65.4

2024-09-011

PRE

Oncolytic adenovirus encoding apolipoprotein A1 suppresses metastasis of triple-negative breast cancer in mice

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

IF12.8

2024-04-030

OAAI

Predictive and prognostic markers from endoscopic ultrasound with biopsies during definitive chemoradiation therapy in esophageal squamous cell carcinoma (vol 23, 681, 2023)

BMC CANCER

IF3.4

2023-07-250

OAAI

Oncolytic viruses engineered to enforce cholesterol efflux restore tumor-associated macrophage phagocytosis and anti-tumor immunity in glioblastoma

设计用于增强胆固醇流出的溶瘤病毒可恢复胶质母细胞瘤中肿瘤相关的巨噬细胞吞噬作用和抗肿瘤免疫

NATURE COMMUNICATIONS

IF15.7

2023-07-2031

OAAI

Spatial distribution of tumor-infiltrating T cells indicated immune response status under chemoradiotherapy plus PD-1 blockade in esophageal cancer

食管癌放化疗加PD-1阻断下肿瘤浸润T细胞的空间分布

FRONTIERS IN IMMUNOLOGY

IF5.9

2023-05-197

OAAI

Artificial intelligence-aided discovery of prolyl hydroxylase 2 inhibitors to stabilize hypoxia inducible factor-1? and promote angiogenesis

CHINESE CHEMICAL LETTERS

IF8.9

2023-02-015

PRE

Functional insights from targeted imaging BACE1: the first near-infrared fluorescent probe for Alzheimer's disease diagnosis

靶向成像的功能见解BACE1: 第一个用于阿尔茨海默病诊断的近红外荧光探针

BIOMATERIALS RESEARCH

IF9.6

2022-12-095

OAAI

Oncolytic vaccinia virus expressing a bispecific T-cell engager enhances immune responses in EpCAM positive solid tumors

表达双特异性T细胞衔接物的溶瘤痘苗病毒增强EpCAM阳性实体瘤的免疫反应

FRONTIERS IN IMMUNOLOGY

IF5.9

2022-11-146

OAAI

STAT5 confers lactogenic properties in breast tumorigenesis and restricts metastatic potential

ONCOGENE

IF7.3

2022-10-194

代谢相关基因对特征分析将肿瘤相关巨噬细胞上的ABCA1表达水平确定为原发性IDHWT胶质母细胞瘤的预后生物标志物

FRONTIERS IN IMMUNOLOGY

IF5.9

2022-09-303

OAAI

BZW1 Facilitates Glycolysis and Promotes Tumor Growth in Pancreatic Ductal Adenocarcinoma Through Potentiating eIF2α Phosphorylation

GASTROENTEROLOGY

IF25.1

2022-04-0139

An Innovative Minimally Invasive Oncoplastic Technique for Early Breast Cancer: The Spoon-Shape Technique

JOURNAL OF CLINICAL MEDICINE

IF2.9

2022-03-021

OAAI

Immunostimulatory Properties of Chemotherapy in Breast Cancer: From Immunogenic Modulation Mechanisms to Clinical Practice

乳腺癌化疗的免疫刺激特性: 从免疫原性调节机制到临床实践

FRONTIERS IN IMMUNOLOGY

IF5.9

2022-01-0523

OAAI

Spatial Distribution and Predictive Significance of Dendritic Cells and Macrophages in Esophageal Cancer Treated With Combined Chemoradiotherapy and PD-1 Blockade

FRONTIERS IN IMMUNOLOGY

IF5.9

2022-01-0322

OAAI

Jie Dong

个人简介

教育背景

工作经历

荣誉奖项

研究方向